3-[(3S)-4-[1,3-benzodioxol-5-yl(methyl)amino]-3-[(2-methylphenyl)sulfonylcarbamoylamino]-4-oxobutyl]benzamide
C27H28N4O7S — CID 135264839
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[(3S)-4-[1,3-benzodioxol-5-yl(methyl)amino]-3-[(2-methylphenyl)sulfonylcarbamoylamino]-4-oxobutyl]benzamide
3-[(3S)-4-[1,3-benzodioxol-5-yl(methyl)amino]-3-[(2-methylphenyl)sulfonylcarbamoylamino]-4-oxobutyl]benzamide (PubChem CID 135264839) has the molecular formula C27H28N4O7S and a molecular weight of 552.61 g/mol. Its IUPAC name is 3-[(3S)-4-[1,3-benzodioxol-5-yl(methyl)amino]-3-[(2-methylphenyl)sulfonylcarbamoylamino]-4-oxobutyl]benzamide.
Molecular Properties
| Compound Name | 3-[(3S)-4-[1,3-benzodioxol-5-yl(methyl)amino]-3-[(2-methylphenyl)sulfonylcarbamoylamino]-4-oxobutyl]benzamide |
|---|---|
| PubChem CID | 135264839 |
| Molecular Formula | C27H28N4O7S |
| Molecular Weight | 552.61 g/mol |
| Exact Mass | 552.17 |
| IUPAC Name | 3-[(3S)-4-[1,3-benzodioxol-5-yl(methyl)amino]-3-[(2-methylphenyl)sulfonylcarbamoylamino]-4-oxobutyl]benzamide |
| SMILES | Cc1ccccc1S(=O)(=O)NC(=O)N[C@@H](CCc1cccc(C(N)=O)c1)C(=O)N(C)c1ccc2c(c1)OCO2 |
| InChI | InChI=1S/C27H28N4O7S/c1-17-6-3-4-9-24(17)39(35,36)30-27(34)29-21(12-10-18-7-5-8-19(14-18)25(28)32)26(33)31(2)20-11-13-22-23(15-20)38-16-37-22/h3-9,11,13-15,21H,10,12,16H2,1-2H3,(H2,28,32)(H2,29,30,34)/t21-/m0/s1 |
| InChIKey | HJFYSXQTXHEYBF-NRFANRHFSA-N |
| XLogP | 2.47 |
| TPSA | 157.13 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 552.61 |
| LogP ≤ 5 | 2.47 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135264839 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.